Checking the Hippo in Sarcomatoid Renal Cell Carcinoma with Immunotherapy.
Publication
, Journal Article
Hwang, JK; Agarwal, N; Brugarolas, J; Zhang, T
Published in: Clin Cancer Res
January 1, 2021
Subset analysis of patients with sarcomatoid renal cell carcinoma (sRCC) included in the CheckMate 214 trial of ipilimumab-nivolumab versus sunitinib showed improved outcomes in sRCC with ipilimumab-nivolumab. The use of checkpoint inhibitor-based regimens in sRCC, for which therapeutic options were once limited, is further supported by additional clinical trials.See related article by Tannir et al., p. 78.
Duke Scholars
Published In
Clin Cancer Res
DOI
EISSN
1557-3265
Publication Date
January 1, 2021
Volume
27
Issue
1
Start / End Page
5 / 7
Location
United States
Related Subject Headings
- Sunitinib
- Protein Serine-Threonine Kinases
- Oncology & Carcinogenesis
- Nivolumab
- Kidney Neoplasms
- Ipilimumab
- Immunotherapy
- Humans
- Hippo Signaling Pathway
- Carcinoma, Renal Cell
Citation
APA
Chicago
ICMJE
MLA
NLM
Hwang, J. K., Agarwal, N., Brugarolas, J., & Zhang, T. (2021). Checking the Hippo in Sarcomatoid Renal Cell Carcinoma with Immunotherapy. Clin Cancer Res, 27(1), 5–7. https://doi.org/10.1158/1078-0432.CCR-20-3506
Hwang, Joyce K., Neeraj Agarwal, James Brugarolas, and Tian Zhang. “Checking the Hippo in Sarcomatoid Renal Cell Carcinoma with Immunotherapy.” Clin Cancer Res 27, no. 1 (January 1, 2021): 5–7. https://doi.org/10.1158/1078-0432.CCR-20-3506.
Hwang JK, Agarwal N, Brugarolas J, Zhang T. Checking the Hippo in Sarcomatoid Renal Cell Carcinoma with Immunotherapy. Clin Cancer Res. 2021 Jan 1;27(1):5–7.
Hwang, Joyce K., et al. “Checking the Hippo in Sarcomatoid Renal Cell Carcinoma with Immunotherapy.” Clin Cancer Res, vol. 27, no. 1, Jan. 2021, pp. 5–7. Pubmed, doi:10.1158/1078-0432.CCR-20-3506.
Hwang JK, Agarwal N, Brugarolas J, Zhang T. Checking the Hippo in Sarcomatoid Renal Cell Carcinoma with Immunotherapy. Clin Cancer Res. 2021 Jan 1;27(1):5–7.
Published In
Clin Cancer Res
DOI
EISSN
1557-3265
Publication Date
January 1, 2021
Volume
27
Issue
1
Start / End Page
5 / 7
Location
United States
Related Subject Headings
- Sunitinib
- Protein Serine-Threonine Kinases
- Oncology & Carcinogenesis
- Nivolumab
- Kidney Neoplasms
- Ipilimumab
- Immunotherapy
- Humans
- Hippo Signaling Pathway
- Carcinoma, Renal Cell